FLAVIA ORTIZ: Open Payments
NPI 1568114395 · PORT ST JOHN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 37 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $40 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $95 |
| ABBVIE INC. | 5 | $82 |
| Exact Sciences Corporation | 3 | $70 |
| Novo Nordisk Inc | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| SHIELD THERAPEUTICS INC | 3 | $46 |
| Lilly USA, LLC | 2 | $46 |
| Corcept Therapeutics | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: TRELEGY ELLIPTA, ACCRUFER, Cologuard Collection Kit, MOUNJARO, Ozempic, Korlym, KEVEYIS, SHINGRIX.
Industry payments across FL — which companies pay providers there.
